These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 23041125

  • 1. A Vaxfectin(®)-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes.
    Veselenak RL, Shlapobersky M, Pyles RB, Wei Q, Sullivan SM, Bourne N.
    Vaccine; 2012 Nov 19; 30(49):7046-51. PubMed ID: 23041125
    [Abstract] [Full Text] [Related]

  • 2. Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection.
    Shlapobersky M, Marshak JO, Dong L, Huang ML, Wei Q, Chu A, Rolland A, Sullivan S, Koelle DM.
    J Gen Virol; 2012 Jun 19; 93(Pt 6):1305-1315. PubMed ID: 22398318
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs.
    Hoshino Y, Dalai SK, Wang K, Pesnicak L, Lau TY, Knipe DM, Cohen JI, Straus SE.
    J Virol; 2005 Jan 19; 79(1):410-8. PubMed ID: 15596834
    [Abstract] [Full Text] [Related]

  • 7. Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes.
    Awasthi S, Huang J, Shaw C, Friedman HM.
    J Virol; 2014 Aug 19; 88(15):8421-32. PubMed ID: 24829358
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpes.
    Bernstein DI, Cardin RD, Bravo FJ, Hamouda T, Pullum DA, Cohen G, Bitko V, Fattom A.
    Vaccine; 2019 Oct 08; 37(43):6470-6477. PubMed ID: 31515143
    [Abstract] [Full Text] [Related]

  • 10. A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs.
    Odegard JM, Flynn PA, Campbell DJ, Robbins SH, Dong L, Wang K, Ter Meulen J, Cohen JI, Koelle DM.
    Vaccine; 2016 Jan 02; 34(1):101-9. PubMed ID: 26571309
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig.
    Bernstein DI, Earwood JD, Bravo FJ, Cohen GH, Eisenberg RJ, Clark JR, Fairman J, Cardin RD.
    Vaccine; 2011 Mar 03; 29(11):2071-8. PubMed ID: 21238569
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Single and combination herpes simplex virus type 2 glycoprotein vaccines adjuvanted with CpG oligodeoxynucleotides or monophosphoryl lipid A exhibit differential immunity that is not correlated to protection in animal models.
    Khodai T, Chappell D, Christy C, Cockle P, Eyles J, Hammond D, Gore K, McCluskie MJ, Evans DM, Lang S, Loudon PT, Townend T, Wright P, West K, Bright H.
    Clin Vaccine Immunol; 2011 Oct 03; 18(10):1702-9. PubMed ID: 21852545
    [Abstract] [Full Text] [Related]

  • 17. Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected.
    Bourne N, Milligan GN, Stanberry LR, Stegall R, Pyles RB.
    J Infect Dis; 2005 Dec 15; 192(12):2117-23. PubMed ID: 16288376
    [Abstract] [Full Text] [Related]

  • 18. A vaccine containing highly purified virus particles in adjuvant provides high level protection against genital infection and disease in guinea pigs challenged intravaginally with homologous and heterologous strains of herpes simplex virus type 2.
    Bernstein DI, Morello CS, Cardin RD, Bravo FJ, Kraynyak KA, Spector DH.
    Vaccine; 2020 Jan 03; 38(1):79-89. PubMed ID: 31611098
    [Abstract] [Full Text] [Related]

  • 19. The prophylactic effect of immunization with DNA encoding herpes simplex virus glycoproteins on HSV-induced disease in guinea pigs.
    McClements WL, Armstrong ME, Keys RD, Liu MA.
    Vaccine; 1997 Jun 03; 15(8):857-60. PubMed ID: 9234533
    [Abstract] [Full Text] [Related]

  • 20. An Interleukin 12 Adjuvanted Herpes Simplex Virus 2 DNA Vaccine Is More Protective Than a Glycoprotein D Subunit Vaccine in a High-Dose Murine Challenge Model.
    Bagley KC, Schwartz JA, Andersen H, Eldridge JH, Xu R, Ota-Setlik A, Geltz JJ, Halford WP, Fouts TR.
    Viral Immunol; 2017 Apr 03; 30(3):178-195. PubMed ID: 28085634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.